Manulife (Manufacturers Life Insurance)
LXEO icon

Manulife (Manufacturers Life Insurance)’s Lexeo Therapeutics LXEO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$102K Sell
17,738
-1,409
-7% -$9.98K ﹤0.01% 2623
2025
Q4 		$190K Buy
+19,147
New +$175K ﹤0.01% 2552

Other funds holding LXEO

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s LXEO Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Lexeo Therapeutics (LXEO) stake by 7.4% in Q1 2026, selling an estimated $9.98K and leaving 17,738 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #2623.

Manulife (Manufacturers Life Insurance) first reported a position in LXEO in Q4 2025 and has held it in 2 quarters since. The position peaked at $190K in Q4 2025. 139 funds tracked by Wall St. Rank hold LXEO as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 17,738 shares of Lexeo Therapeutics worth $102K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 1,409 Lexeo Therapeutics shares in Q1 2026, an estimated $9.98K.
  • Lexeo Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2623 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Lexeo Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Lexeo Therapeutics position peaked at $190K in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.